Papillary renal cell carcinoma (PRCC) is a type of kidney cancer. It starts in the small tubes in the kidneys that filter waste from the blood. PRCC may be Type 1 or Type 2, which can affect the ...

Although kidney cancer remains relatively uncommon in young adults, it is not unheard of. Large surgical series have found that only about 5% of renal cell carcinoma (RCC) patients are younger than 40 ...

Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, exactly, it may mean. Developing a good understanding of your disease—and ...

Kidney cancer is among the ten most common cancers worldwide, with its incidence steadily rising due to ageing populations, ...

The new chemotherapy option is called Jelmyto, approved by FDA to treat renal pelvis cancer.

Kidney cancer is a disease where cancer cells begin to develop abnormally in the kidneys. As cancer cells grow rapidly, they can form a tumor, and eventually, the cancer can spread to other parts of ...

A common genetic mutation that helps some kidney cancers survive may also expose an unexpected weakness, one that MUSC ...

The renal cancer pipeline presents key opportunities in developing novel therapies targeting immunosuppression and oncogenic pathways. Notable advancements include combinations like Quavonlimab with ...